EBV Ea-R p85 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, a histone deacetylase inhibitor, can alter chromatin structure and gene expression, potentially affecting EBV latency and reactivation. By modifying the epigenetic landscape, it may indirectly suppress EBV Ea-R p85 expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 inhibits NF-κB activation, a pathway critical for EBV-mediated B-cell transformation and viral gene expression. Inhibition of NF-κB could reduce EBV Ea-R p85 levels by limiting essential transcriptional support. | ||||||
3′-Azido-3′-deoxythymidine | 30516-87-1 | sc-203319 | 10 mg | $61.00 | 2 | |
3′-Azido-3′-deoxythymidine, a nucleoside reverse transcriptase inhibitor, primarily targets HIV but may exert indirect effects on EBV replication and associated proteins like EBV Ea-R p85 through nucleoside analog mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, disrupts signaling pathways involved in cell survival and proliferation. By inhibiting PI3K, it could indirectly affect the cellular environment conducive to EBV Ea-R p85 expression. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
Ibrutinib, a Bruton's tyrosine kinase inhibitor, impacts B-cell receptor signaling. Given the role of BCR signaling in EBV latency and reactivation, ibrutinib may indirectly influence EBV Ea-R p85 levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine, an antimalarial, affects endosomal acidification and autophagy. By modulating autophagic processes, it may impact EBV lifecycle and indirectly affect EBV Ea-R p85 expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid with anti-inflammatory and antioxidant properties, may influence EBV infection dynamics and associated protein expression, including EBV Ea-R p85, by modulating cellular signaling pathways. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram, an aldehyde dehydrogenase inhibitor, has been shown to have antiviral effects. Its ability to modulate cellular processes could indirectly affect EBV Ea-R p85 by altering viral replication or protein stabilization. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, with anti-inflammatory and antiviral properties, may modulate NF-κB and other signaling pathways relevant to EBV infection and latency, potentially affecting EBV Ea-R p85 expression. | ||||||
Indirubin | 479-41-4 | sc-201531 sc-201531A | 5 mg 25 mg | $114.00 $525.00 | 4 | |
Indirubin, a cyclin-dependent kinase inhibitor, impacts cell cycle regulation. Through its effects on cellular proliferation and signaling pathways, it may indirectly suppress EBV Ea-R p85 expression. | ||||||